(Q47952446)

7 February 2018

title

Gut-brain actions underlying comorbid anxiety and depression associated with inflammatory bowel disease (English)

1 reference

7 February 2018

inflammatory bowel diseases

main subject

1 reference

Áine Abautret-Daly

1

1 reference

7 February 2018

Elaine Dempsey

2

1 reference

7 February 2018

Adolfo Parra-Blanco

3

1 reference

7 February 2018

Carlos Medina

4

1 reference

7 February 2018

Andrew Harkin

5

1 reference

7 February 2018

publication date

8 March 2017

1 reference

7 February 2018

published in

Acta Neuropsychiatrica

1 reference

7 February 2018

page(s)

1-22

1 reference

7 February 2018

Depressive mood and disease activity in inflammatory bowel disease

cites work

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Chronic psychosocial stress increases the risk for inflammation-related colon carcinogenesis in male mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Life-event stress induced by the Great East Japan Earthquake was associated with relapse in ulcerative colitis but not Crohn's disease: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

An acute stressor enhances sensitivity to a chemical irritant and increases 51CrEDTA permeability of the colon in adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Better disease specific patient knowledge is associated with greater anxiety in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

An exploration of family problem-solving and affective involvement as moderators between disease severity and depressive symptoms in adolescents with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Short-term stress, but not mucosal healing nor depression was predictive for the risk of relapse in patients with ulcerative colitis: a prospective 12-month follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Psychological well-being and quality of life in Crohn's disease patients with an ostomy: a preliminary investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Depressive symptoms in Crohn's disease: relationship with immune activation and tryptophan availability

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Association between depressive symptoms and incidence of Crohn's disease and ulcerative colitis: results from the Nurses' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Correlation between depression, anxiety, and polymorphonuclear cells' resilience in ulcerative colitis: the mediating role of heat shock protein 70.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Antidepressant use among paediatric patients with recent-onset inflammatory bowel disease: a nationwide case control study in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Campylobacter jejuni infection increases anxiety-like behavior in the holeboard: possible anatomical substrates for viscerosensory modulation of exploratory behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Depression subtypes in pediatric inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Normal gut microbiota modulates brain development and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Perianal disease is associated with psychiatric co-morbidity in Crohn's disease in remission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Risk factors for depression in the elderly inflammatory bowel disease population

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Snapshot of an integrated psychosocial gastroenterology service

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Concerns and worries in people living with inflammatory bowel disease (IBD): A mixed methods study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Treatment with immunosuppressive therapy may improve depressive symptoms in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Predictors of depression in youth with Crohn disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Remission on thiopurinic immunomodulators normalizes quality of life and psychological status in patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

A new prebiotic from germinated barley for nutraceutical treatment of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Randomized efficacy trial of two psychotherapies for depression in youth with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

The relationship between coping, health competence and patient participation among patients with inactive inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Controversies Revisited: A Systematic Review of the Comorbidity of Depression and Anxiety with Inflammatory Bowel Diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Role of antibiotics for treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Role of the normal gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Surgery for inflammatory bowel disease in the era of laparoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

The human gut microbiome: current knowledge, challenges, and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Activation in vagal afferents and central autonomic pathways: early responses to intestinal infection with Campylobacter jejuni

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Combined administration of secretin and oxytocin inhibits chronic colitis and associated activation of forebrain neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Brain effects of chronic IBD in areas abnormal in autism and treatment by single neuropeptides secretin and oxytocin

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Gastrointestinal issues in autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Neuronal activity and CRF receptor gene transcription in the brains of rats with colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Sex-dependent control of murine emotional-affective behaviour in health and colitis by peptide YY and neuropeptide Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Genesis of anxiety, depression, and ongoing abdominal discomfort in ulcerative colitis-like colon inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Effects of free radicals and leukocytes on increases in blood-brain barrier permeability during colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

The blood-brain barrier in systemic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Modulation of the microbiota-gut-brain axis by probiotics in a murine model of inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Bacterial infection causes stress-induced memory dysfunction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Behavioral despair associated with a mouse model of Crohn's disease: Role of nitric oxide pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Chronological assessment of mast cell-mediated gut dysfunction and mucosal inflammation in a rat model of chronic psychosocial stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Aggravation of DSS-induced colitis after chronic subordinate colony (CSC) housing is partially mediated by adrenal mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Adrenal insufficiency and colonic inflammation after a novel chronic psycho-social stress paradigm in mice: implications and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Maternal separation as a model of brain–gut axis dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

C57BL/6 and congenic interleukin-10-deficient mice can serve as models of Campylobacter jejuni colonization and enteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

The immunological and genetic basis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Dextran sulfate sodium (DSS) colitis in rats: clinical, structural, and ultrastructural aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Animal models of inflammatory bowel disease: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Predictors of abdominal pain in depressed pediatric inflammatory bowel disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Abdominal pain and the neurotrophic system in ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

An anti-inflammatory diet as treatment for inflammatory bowel disease: a case series report

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Assessing fatigue in inflammatory bowel disease: comparison of three fatigue scales

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

The incidence and risk factors for developing depression after being diagnosed with inflammatory bowel disease: a cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Review article: psychosocial factors in the quality of life of patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Risk factors of anxiety and depression in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Inflammation and social experience: an inflammatory challenge induces feelings of social disconnection in addition to depressed mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Sickness behavior as a new target for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

IBD and health-related quality of life -- discovering the true impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Regulation and function of immediate-early genes in the brain: beyond neuronal activity markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Measurement of immediate-early gene activation- c-fos and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

The HPA axis in major depression: classical theories and new developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Effects of cytokines on glucocorticoid receptor expression and function. Glucocorticoid resistance and relevance to depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Cytokine targets in the brain: impact on neurotransmitters and neurocircuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Synaptic scaling mediated by glial TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

From inflammation to sickness and depression: when the immune system subjugates the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Surgery for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Multiple roles for astrocytes as effectors of cytokines and inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Guidelines for the management of inflammatory bowel disease in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Microglia as a source and target of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Guidelines for the management of inflammatory bowel disease in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Dextran sulfate sodium-induced colitis alters stress-associated behaviour and neuropeptide gene expression in the amygdala-hippocampus network of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Cytokine-associated emotional and cognitive disturbances in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Dose-dependent effects of endotoxin on neurobehavioral functions in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Depression and cardiovascular disease: a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Depression in patients with rheumatoid arthritis: description, causes and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Psychological stress and inflammatory bowel disease: a follow-up study in parents who lost a child in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Depression and anxiety in people with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Crohn's disease: a two-year prospective study of the association between psychological distress and disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Functional magnetic resonance imaging study reveals differences in the habituation to psychological stress in patients with Crohn's disease versus healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Brain functional changes in patients with ulcerative colitis: a functional magnetic resonance imaging study on emotional processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Increased risks of developing anxiety and depression in young patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

HPA-axis responses during experimental colitis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case-matched observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Long-term expression of corticotropin-releasing factor (CRF) in the paraventricular nucleus of the hypothalamus in response to an acute colonic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Inflammatory bowel disease: clinical aspects and established and evolving therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Extraintestinal Manifestations of Inflammatory Bowel Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Ulcerative colitis exacerbates lipopolysaccharide-induced damage to the nigral dopaminergic system: potential risk factor in Parkinson`s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Neuroimmunomodulative properties of dipeptidyl peptidase IV/CD26 in a TNBS-induced model of colitis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Expression of interleukin 6 in brain and colon of rats with TNBS-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Intestinal inflammation and seizure susceptibility: understanding the role of tumour necrosis factor-alpha in a rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Determinants of life satisfaction in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Microglial activation and TNFalpha production mediate altered CNS excitability following peripheral inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Cytokines in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Disruption of the blood-brain barrier during TNBS colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

7 January 2021

Chronic intestinal inflammation alters hippocampal neurogenesis

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

7 January 2021

c-Fos expression in the myenteric plexus, spinal cord and brainstem following injection of formalin in the rat colonic wall

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

7 January 2021

Psychological stress promotes neutrophil infiltration in colon tissue through adrenergic signaling in DSS-induced colitis model

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

7 January 2021

Cytokine activation of the HPA axis.

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

7 January 2021

Cytokine networks in neuroinflammation

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

7 January 2021

Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

7 January 2021

Probiotics: the scientific basis.

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

7 January 2021

El papel de la ansiedad y la depresión en las recidivas de la enfermedad inflamatoria intestinal

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

7 January 2021

Mortality in inflammatory bowel disease: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

7 January 2021

State and trait anxiety and depression in patients affected by gastrointestinal diseases: psychometric evaluation of 1641 patients referred to an internal medicine outpatient setting

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

7 January 2021

What is the peak age for onset of IBD?

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

7 January 2021

Temporal comorbidity of mental disorder and ulcerative colitis

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

7 January 2021

A study of the effects of restraint stress on colitis induced by dextran sulphate sodium in singly housed rats

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

7 January 2021

Classification of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

7 January 2021

Dietary Intake and Risk of Developing Inflammatory Bowel Disease: A Systematic Review of the Literature

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

7 January 2021

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

7 January 2021

May the Force Be With You: The Light and Dark Sides of the Microbiota-Gut-Brain Axis in Neuropsychiatry

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

7 January 2021

Factors affecting health related quality of life of patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

7 January 2021

Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

7 January 2021

Evidence that colitis is initiated by environmental stress and sustained by fecal factors in the cotton-top tamarin (Saguinus oedipus)

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

7 January 2021

Hapten-induced model of chronic inflammation and ulceration in the rat colon

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

7 January 2021

A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

7 January 2021

Behavioral evaluation of visceral pain in a rat model of colonic inflammation

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2017.3

7 January 2021

Identifiers

DOI

10.1017/NEU.2017.3

1 reference

7 February 2018

release_vg3h7dossrdfrh3q35cvqwjaji

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vg3h7dossrdfrh3q35cvqwjaji

24 November 2022

mapped directly with Wikidata item

1 reference

7 February 2018